Immune-Mediated Liver Disease Special Interest Group 

The Immune-Mediated Liver Disease Special Interest Group (SIG) is an affiliate of the British Association for Study of Liver Disease (BASL) and cross cuts existing programmes of activity as part of UK-PSC, UK-PBC, UK-AIH and IgG4-related hepatobiliary disease. The remit of this programme will be to generate high quality multi-centre observational cohort studies, increase patient registration to each of the core UK-autoimmune liver disease strands, and perhaps most importantly, develop collaborative grant applications on a larger scale, focussing on key areas of research priority set out by patients, clinicians and industry.  If anyone wishes to join the group please contact the BASL secretariat on Samantha@basl.org.uk.  

Steering Committee

Dr Palak Trivedi (Chair), University Hospitals Birmingham

Dr Richard Aspinall, Queen Alexandra Hospital, Portsmouth

Dr Emma Culver, Royal Free Hospital, London

Dr Jessica Dyson, Freeman Hospital, Newcastle Upon Tyne

Professor Michael Heneghan, King's College Hospital, London

Professor David Jones, Newcastle University

Dr George Mells, Addenbrooke's Hospital, Cambridge

Dr Douglas Thorburn, Royal Free Hospital, London

Dr Andrew Yeoman, Royal Gwent Hospital

 

Patient representatives:

Ann Brownlee, AIH Support

Robert Mitchell-Thain, PBC Foundation

Martine Walmsley, PSC Support

Resources

To be added following the first SIG meeting.

Join Basl - BASL Membership covers membership to BASL and all of it BASL 2019 - The BASL Annual Meeting is the highlight of the BASL calendar and the main liver meeting in the UK. Strathclyde University, Glasgow, 18th - 20th September 2019 BASL Events - BASL and the BASL Sub Groups run an exciting and varied calendar of educational events throughout the year, as well as endorsing other not to miss events. Click here to Book Now.